Most bought healthcare stocks in Q2 2020
See which Healthcare stocks institutional investors increased the most in Q2 2020, measured as net growth in reported share positions from Q1 2020 into Q2 2020. Notable additions at the top of this list include CERUS CORP (CERS), ENVISTA HOLDINGS CORP (NVST), ABBVIE INC (ABBV), ZENTALIS PHARMACEUTICALS INC (ZNTL). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| CERS | CERUS CORP | 7,753,379 | $78.48K | 0 | 1 | 0 | 0 | 1 |
| NVST | ENVISTA HOLDINGS CORP | 7,181,637 | $172.91K | 1 | 1 | 0 | 0 | 2 |
| ABBV | ABBVIE INC | 5,666,815 | $864.56K | 2 | 3 | 5 | 0 | 11 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 4,443,284 | $213.37K | 1 | 0 | 0 | 0 | 1 |
| MCRB | SERES THERAPEUTICS INC | 4,148,123 | $31.32K | 0 | 2 | 0 | 0 | 2 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 4,038,433 | $15.63K | 0 | 1 | 0 | 0 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3,348,094 | $89.70K | 0 | 1 | 0 | 0 | 1 |
| EXEL | EXELIXIS INC | 2,927,494 | $200.60K | 0 | 1 | 1 | 0 | 2 |
| HCA | HCA HEALTHCARE INC | 2,488,704 | $274.54K | 1 | 4 | 0 | 0 | 5 |
| ABT | ABBOTT LABORATORIES | 2,404,733 | $452.60K | 2 | 2 | 2 | 1 | 8 |
| EDIT | EDITAS MEDICINE INC | 2,010,226 | $119.42K | 0 | 1 | 2 | 0 | 3 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 1,905,073 | $79.94K | 1 | 3 | 0 | 1 | 5 |
| VCYT | VERACYTE INC | 1,797,934 | $51.76K | 0 | 1 | 0 | 0 | 1 |
| TMO | THERMO FISHER SCIENTIFIC INC | 1,667,522 | $725.33K | 1 | 2 | 6 | 1 | 9 |
| AMRN | AMARIN CORP PLC -ADR | 1,449,260 | $17.10K | 0 | 1 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 1,423,735 | $425.51K | 0 | 2 | 1 | 1 | 3 |
| EHC | ENCOMPASS HEALTH CORP | 1,330,331 | $78.91K | 0 | 3 | 0 | 0 | 3 |
| CLLS | CELLECTIS - ADR | 1,231,281 | $35.23K | 0 | 1 | 0 | 0 | 1 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 1,211,314 | $38.05K | 0 | 1 | 1 | 0 | 2 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,205,093 | $115.33K | 1 | 1 | 0 | 0 | 2 |
| TWST | TWIST BIOSCIENCE CORP | 999,397 | $54.75K | 0 | 1 | 0 | 0 | 1 |
| PSNL | PERSONALIS INC | 964,618 | $17.92K | 0 | 1 | 0 | 0 | 1 |
| XRAY | DENTSPLY SIRONA INC | 903,580 | $96.60K | 1 | 1 | 2 | 1 | 4 |
| SYK | STRYKER CORP | 865,914 | $263.23K | 0 | 5 | 0 | 1 | 5 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 854,385 | $271.91K | 0 | 2 | 1 | 1 | 5 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 854,237 | $203.04K | 2 | 1 | 0 | 0 | 3 |
| EXAS | EXACT SCIENCES CORP | 821,717 | $144.57K | 0 | 1 | 1 | 0 | 2 |
| EW | EDWARDS LIFESCIENCES CORP | 786,408 | -$167.30K | 0 | 5 | 0 | 3 | 5 |
| ZTS | ZOETIS INC | 767,099 | $409.63K | 2 | 3 | 2 | 1 | 7 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 765,382 | $118.88K | 0 | 1 | 0 | 0 | 1 |
| MNKD | MANNKIND CORP | 762,715 | $1.33K | 1 | 0 | 0 | 0 | 1 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 690,600 | $21.60K | 0 | 1 | 0 | 0 | 1 |
| GMAB | GENMAB A/S -SP ADR | 666,012 | $37.42K | 0 | 1 | 2 | 0 | 3 |
| TGTX | TG THERAPEUTICS INC | 643,600 | $17.47K | 0 | 1 | 0 | 0 | 1 |
| INVA | INNOVIVA INC | 632,894 | $30.94K | 0 | 2 | 0 | 0 | 2 |
| PDCO | PATTERSON COS INC | 624,775 | $16.06K | 0 | 1 | 1 | 0 | 2 |
| CORT | CORCEPT THERAPEUTICS INC | 617,155 | $51.31K | 0 | 1 | 0 | 0 | 1 |
| TXG | 10X GENOMICS INC-CLASS A | 615,653 | $55.27K | 1 | 1 | 0 | 0 | 2 |
| HALO | HALOZYME THERAPEUTICS INC | 613,753 | $33.73K | 0 | 1 | 2 | 0 | 3 |
| DXCM | DEXCOM INC | 573,293 | $361.64K | 1 | 1 | 0 | 0 | 2 |
| REGN | REGENERON PHARMACEUTICALS | 525,662 | $627.18K | 0 | 2 | 0 | 2 | 2 |
| CDNA | CAREDX INC | 487,358 | $27.99K | 0 | 1 | 0 | 0 | 1 |
| CLDX | CELLDEX THERAPEUTICS INC | 466,988 | $19.34K | 0 | 1 | 0 | 0 | 1 |
| FATE | FATE THERAPEUTICS INC | 464,748 | $22.66K | 0 | 1 | 0 | 0 | 1 |
| HSIC | HENRY SCHEIN INC | 434,257 | $36.45K | 1 | 2 | 1 | 0 | 4 |
| CLSD | CLEARSIDE BIOMEDICAL INC | 418,550 | $858 | 0 | 1 | 0 | 0 | 1 |
| BDX | BECTON DICKINSON AND CO | 417,662 | $197.73K | 1 | 5 | 4 | 1 | 10 |
| PCRX | PACIRA BIOSCIENCES INC | 382,655 | $66.82K | 0 | 1 | 0 | 0 | 1 |
| VNDA | VANDA PHARMACEUTICALS INC | 380,168 | $8.51K | 0 | 1 | 0 | 0 | 1 |
| PBYI | PUMA BIOTECHNOLOGY INC | 377,100 | $6.10K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2020
What are the most bought Healthcare stocks in Q2 2020?
The most bought healthcare stocks in Q2 2020 are those with the largest increase in reported share counts across tracked institutional investors compared to Q1 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2020?
Among the managers we track, net additions were largest in companies such as CERUS CORP (CERS), ENVISTA HOLDINGS CORP (NVST), ABBVIE INC (ABBV), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2020).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.